U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...
We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Long-Term Pick. In this article, we will summarize ...
NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn ...
Most companies don't survive for decades, much less pay regular dividends for that long. Healthcare leaders Merck (NYSE: MRK) ...
Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...
Companies that pay dividends have been a reliable choice for investors seeking a passive and somewhat stable income.
The FDA on Tuesday signed off on SpringWorks Therapeutics’ mirdametinib—now to carry the brand name Gomekli—for the treatment ...
Tuesday, the agency signed off on SpringWorks’ Gomekli (mirdametinib) as a treatment for the rare genetic disorder ...
The table below is a review of notable updates that occurred in January 2025 for investigational products in development.
(Corrects third to last paragraph to say "the erosion from LOEs (loss of exclusivity)", not "from LOEs (levels of evidence)") ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results